Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1238937

	registered interest
	date	29/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people with blood cancer have had (a) CAR-T cell therapy and (b) a stem cell transplant in each of the last six months for which data is available.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	96848
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>The data collected is for all conditions that are commissioned for stem cell transplant by NHS England and NHS Improvement. It should be noted that there will be changes to the data in the last quarter due to the time lag in the reporting arrangements.</p><table><tbody><tr><td><p> </p></td><td><p>Stem Cell Transplants</p></td></tr><tr><td><p>March 2020</p></td><td><p>164</p></td></tr><tr><td><p>April 2020</p></td><td><p>69</p></td></tr><tr><td><p>May 2020</p></td><td><p>63</p></td></tr><tr><td><p>June 2020</p></td><td><p>89</p></td></tr><tr><td><p>July 2020</p></td><td><p>120</p></td></tr><tr><td><p>August 2020</p></td><td><p>123</p></td></tr><tr><td><p>Total</p></td><td><p>628</p></td></tr></tbody></table><p><br>The numbers for CAR-T are collected via an alternative route and are correct to the end of September 2020.</p><table><tbody><tr><td><p> </p></td><td><p>CAR-T infusions</p></td></tr><tr><td><p>April 2020</p></td><td><p>13</p></td></tr><tr><td><p>May 2020</p></td><td><p>17</p></td></tr><tr><td><p>June 2020</p></td><td><p>21</p></td></tr><tr><td><p>July 2020</p></td><td><p>21</p></td></tr><tr><td><p>August 2020</p></td><td><p>9</p></td></tr><tr><td><p>September 2020</p></td><td><p>24</p></td></tr><tr><td><p>Total</p></td><td><p>105</p></td></tr></tbody></table> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:02:12 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1387546

	registered interest
	date	13/12/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Heart Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that the (a) detection and diagnostic processes and (b) subsequent support for patients with heart valve disease is not affected by a potential reduction in face-to-face GP appointments aimed at supporting the covid-19 booster vaccine rollout.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	92141
	answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>General practices will remain open but have been asked to prioritise vaccinations and emergency care for the rest of the year. General practitioners will still be able to refer patients with a heart condition to one of 40 new diagnostic centres to access detection and diagnostic checks closer to home.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 90402 question first answered 20/12/2021 10:29:28 answering member 4492 label Biography information for Maria Caulfield
	tabling member	3960 label Biography information for Henry Smith

1060965

	registered interest
	date	14/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Counselling
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans the Government has to ensure that people with cancer are able to access psychological and emotional support.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	909320
	answer	answer is ministerial correction date of answer 19/02/2019 answer text <p>By 2021, every person diagnosed with cancer will have access, where appropriate, to personalised care, including a needs assessment, a care plan and health and wellbeing information and support. The needs assessment guides a conversation about the person’s holistic needs (physical, psychosocial, financial and social) in order to identify any concerns, including psychological and emotional.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/02/2019 17:25:31 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

1386594

	registered interest
	date	09/12/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Heart Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reassure people experiencing symptoms of heart valve disease that they will have access to a face to face GP appointment during the covid-19 booster vaccine rollout.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	90402
	answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>General practices will remain open but have been asked to prioritise vaccinations and emergency care for the rest of the year. General practitioners will still be able to refer patients with a heart condition to one of 40 new diagnostic centres to access detection and diagnostic checks closer to home.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 92141 question first answered 20/12/2021 10:29:28 answering member 4492 label Biography information for Maria Caulfield
	tabling member	3960 label Biography information for Henry Smith

451413

	registered interest
	date	03/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mental Health Services: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the quantity and quality of specialist therapeutic support available to children who have experienced abuse.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	903553
	answer	answer is ministerial correction date of answer 09/02/2016 answer text <p>Children who have been abused may require a range of services to meet their needs. Local commissioners are responsible for assessing local need and ensuring the delivery of appropriate services. Local partners and NHS England need to work together to help children who have experienced abuse or neglect access appropriate care pathways and evidence-based care.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 09/02/2016 15:03:25 answering member 1201 label Biography information for Alistair Burt
	tabling member	3960 label Biography information for Henry Smith

1156063

	registered interest
	date	24/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans the Government has to ensure that GPs follow NICE guidance on blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	900212
	answer	answer is ministerial correction date of answer 30/10/2019 answer text <p>The National Institute for Health and Care Excellence’s (NICE) clinical guidelines help healthcare professionals deliver the best possible care based on the best available evidence. The guidelines are not mandatory, although healthcare professionals are expected to take them fully into account</p><p><br>NICE’s updated referral guidelines for suspected cancer published in June 2015 could save about 5,000 lives a year, with general practitioners urged to think of cancer sooner and to lower the referral threshold for tests.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 30/10/2019 07:32:29 answering member 4380 label Biography information for Jo Churchill previous answer version 2614 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232426

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the NHS Long Term Plan, when the national Quality of Life metric will be implemented to better support people living with blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86638
	answer	answer is ministerial correction date of answer 24/02/2021 answer text <p>The Quality of Life Metric survey will help us better support people, including blood cancer patients, living with and beyond cancer. The survey, launched in September 2020, will initially be sent to people with breast, prostate and colorectal cancer. All other cancers will be included from 2021.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 24/02/2021 03:02:39 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232425

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if a representative from his Department will meet with the blood cancer community to discuss how patient initiated follow-ups could best support patients with blood cancer, during and beyond the covid-19 outbreak.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86637
	answer	answer is ministerial correction date of answer 23/10/2020 answer text <p>No immediate plans are in place to meeting with any members of the blood cancer community.</p><p>Support and information for all cancer patients, including blood cancer patients, is provided through four personalised care interventions:</p><p>- Personalised care and support planning based on holistic needs assessments;</p><p>- Health and wellbeing information and support (including nutritional advice and psychological support);</p><p>- End of treatment summaries, that provide symptom management information; and</p><p>- A Cancer Care Review with their general practitioner.</p><p>As outlined in the NHS Long Term Plan, these interventions will be implemented by 2021.</p><p>During the COVID-19 pandemic, all personalised care and support should be continuing by telephone, video, online or by post if face to face appointments and group sessions have not been possible.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/10/2020 11:56:51 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232422

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what role patient organisations have had in developing the guidance entitled Using patient initiated follow-ups as part of the NHS covid-19 recovery, published by NHS England on 7 August 2020.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86636
	answer	answer is ministerial correction date of answer 22/09/2020 answer text <p>NHS England and NHS Improvement are working with a range of rapid adopter sites to implement patient-initiated follow-ups as part of the restoration of services following COVID-19. This includes joint work to monitor uptake in these sites. Alongside this, 50 trusts provided information detailing their implementation of patient-initiated follow-up this summer. For the longer term, NHS England and NHS Improvement are working with NHS Digital and other organisations to seek to capture further data on patient initiated follow-up usage in future.</p><p>The initial guidance was prepared in rapid response to the need to restore outpatient services following COVID-19. The Academy of Medical Royal Colleges patient lay committee was involved in the development of the guidance. We are working nationally with the NHS England and NHS Improvement personalised care group to engage further with patients and patient organisations as part of the ongoing development of supplementary guidance and tools for local systems. The guidance includes a recommendation that providers/systems carry out local patient engagement as part of implementation.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 86635 question first answered 22/09/2020 13:24:22 answering member 4362 label Biography information for Edward Argar
	tabling member	3960 label Biography information for Henry Smith

1232420

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps NHS England is taking to monitor uptake of its Using patient initiated follow-ups as part of the NHS covid-19 recovery guidance published on 7 August 2020.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86635
	answer	answer is ministerial correction date of answer 22/09/2020 answer text <p>NHS England and NHS Improvement are working with a range of rapid adopter sites to implement patient-initiated follow-ups as part of the restoration of services following COVID-19. This includes joint work to monitor uptake in these sites. Alongside this, 50 trusts provided information detailing their implementation of patient-initiated follow-up this summer. For the longer term, NHS England and NHS Improvement are working with NHS Digital and other organisations to seek to capture further data on patient initiated follow-up usage in future.</p><p>The initial guidance was prepared in rapid response to the need to restore outpatient services following COVID-19. The Academy of Medical Royal Colleges patient lay committee was involved in the development of the guidance. We are working nationally with the NHS England and NHS Improvement personalised care group to engage further with patients and patient organisations as part of the ongoing development of supplementary guidance and tools for local systems. The guidance includes a recommendation that providers/systems carry out local patient engagement as part of implementation.</p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 86636 question first answered 22/09/2020 13:24:22 answering member 4362 label Biography information for Edward Argar
	tabling member	3960 label Biography information for Henry Smith

1232419

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to introduce a shared decision-making model within the NHS to help meet the complex needs of people living with blood cancers throughout their patient journey.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86634
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>The NHS Long Term Plan sets the ambition to offer personalised care to all cancer patients and transform follow-up care, giving people choice and control over the way their care is planned and delivered. This includes ensuring that shared decision-making in care, and personalised care and support planning, are routine for all patients including those with blood cancer.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:37:17 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232418

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of covid-19 on people living with blood cancer being able to make an informed choice on their long-term care and treatment.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86633
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>Support and information for all cancer patients, including blood cancer patients, is provided through four personalised care interventions:</p><p>- Personalised care and support planning based on holistic needs assessments;</p><p>- Health and wellbeing information and support, including nutritional advice and psychological support;</p><p>- End of treatment summaries, that provide symptom management information; and</p><p>- A Cancer Care Review with their general practitioner.</p><p>As outlined in the NHS Long Term Plan, these interventions will be implemented in full by 2021.</p><p>During the COVID-19 pandemic, all personalised care and support has continued by telephone, video, online or by post if face to face appointments and group sessions have not been possible.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:22:35 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232417

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the increased (a) risk and (b) effect of covid-19 on people living with blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86632
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>Blood cancer patients have a higher chance of severe disease if they contract COVID-19 compared to other cancers, which is why they were placed on the extremely clinically vulnerable list and were advised to shield. During the height of the COVID-19 pandemic, some treatments were delayed when the risk of contracting coronavirus was higher than the risk of delaying treatment.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:29:21 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232415

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the rising incidence of blood cancer on the funding requirements of NHS services for blood cancer patients.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86631
	answer	answer is ministerial correction date of answer 22/10/2020 answer text <p>The amount spent by the National Health Service on blood cancer-related services is not collected separately to the overall spend on cancer services.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 22/10/2020 13:00:25 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1232414

	registered interest
	date	08/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chemotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 29 May 2020 to Question 43622, how many people received chemotherapy treatment in (a) May 2019, (b) June 2019, (c) April 2020, (d) May 2020 and (e) June 2020 for the treatment of (i) breast cancer, (ii) bowel cancer, (iii) lung cancer, (iv) blood cancer and (v) prostate cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	86630
	answer	answer is ministerial correction date of answer 10/11/2020 answer text <p>The data in the following table shows first or subsequent treatment of chemotherapy in May 2019, June 2019, April 2020, May 2020 and June 2020 for the treatment of breast cancer, lower intestinal cancer, lung cancer, urological cancer and haematological cancer:</p><table><tbody><tr><td><p> </p></td><td><p>Breast</p></td><td><p>Lower Gastrointestinal</p></td><td><p>Lung</p></td><td><p>Urological</p></td><td><p>Haematological</p></td></tr><tr><td><p>May 2019</p></td><td><p>1,856</p></td><td><p>1,148</p></td><td><p>1,154</p></td><td><p>817</p></td><td><p>1,982</p></td></tr><tr><td><p>June 2019</p></td><td><p>1,744</p></td><td><p>1,127</p></td><td><p>1,070</p></td><td><p>793</p></td><td><p>2,021</p></td></tr><tr><td><p>April 2020</p></td><td><p>1,044</p></td><td><p>750</p></td><td><p>639</p></td><td><p>381</p></td><td><p>1,335</p></td></tr><tr><td><p>May 2020</p></td><td><p>1,480</p></td><td><p>1,066</p></td><td><p>815</p></td><td><p>508</p></td><td><p>1,525</p></td></tr><tr><td><p>June 2020</p></td><td><p>1,610</p></td><td><p>1,095</p></td><td><p>863</p></td><td><p>725</p></td><td><p>1,697</p></td></tr></tbody></table> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 10/11/2020 12:26:03 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1383942

	registered interest
	date	01/12/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the timescale is for HNS England's evaluation report on the performance of Rapid Diagnostic Centres.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	85238
	answer	answer is ministerial correction date of answer 09/12/2021 answer text <p>Ipsos MORI, in collaboration with the Midlands and Lancashire Commissioning Support Unit and York Health Economics Consortium, have been commissioned to undertake a four year evaluation of the rapid diagnostic centre programme until the end of 2023/24. Throughout the evaluation, Ipsos MORI and their partners will produce quarterly and annual reports. The first annual report will be published shortly. The final report is due in March 2024.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 09/12/2021 13:51:18 answering member 4362 label Biography information for Edward Argar
	tabling member	3960 label Biography information for Henry Smith

1231662

	registered interest
	date	04/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 June 2020 to Question 58767, what plans he has to centrally collate data on the total number of severe asthma patients (a) in England and (b) within each of the NHS E+I regions.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	85020
	answer	answer is ministerial correction date of answer 22/09/2020 answer text <p>There are no plans for this.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 22/09/2020 14:46:46 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1231661

	registered interest
	date	04/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 June 2020 to Question 58769, what assessment he has made of the decline to the number of patients accessing biologics therapies for severe asthma in January to March 2020, and what he has to reverse that decline.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	85019
	answer	answer is ministerial correction date of answer 19/10/2020 answer text <p>The National Institute for Health and Care Excellence COVID-19 rapid guideline on severe asthma provides guidance on starting or continuing on biological treatments, for people with severe asthma during the COVID-19 outbreak. The recommendations were written in collaboration with the NHS England Severe Asthma Collaborative. In writing the guidance, particular attention was paid to streamlining the process of moving patients onto biologic therapies to compensate for any possible barriers that may have occurred as a result of changes to the National Health Service, which were made as part of the necessary response to COVID-19.</p><p>Further work is being undertaken by the collaborative to share best practice on providing care to people with severe asthma to ensure on-going provision of high-quality care and to accelerate the initiation of biologics where required.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 19/10/2020 10:33:39 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1231660

	registered interest
	date	04/09/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 June 2020 to Question 60724, what steps his Department is taking to ensure at-home treatment of severe asthma patients is available and offered to all patients; and what assessment has been made of the clinical capacity released within respiratory units as a result of such home management.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	85018
	answer	answer is ministerial correction date of answer 05/11/2020 answer text <p>Specialist respiratory services for severe asthma, along with urgent and emergency treatment for other serious complaints, have continued throughout the COVID-19 outbreak. In most cases people with severe asthma have been able to receive their medication at home instead of having to attend hospital through increasing home care support and via access to remote outpatient consultations for new patients.</p><p>Although clinical capacity was re-directed to support care of patients with COVID-19 and this need has reduced, trusts are also required to prepare for potential future waves of COVID-19 and this will affect the clinical capacity required particularly in respiratory units. Regions have oversight of the local plans developed by each trust.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 05/11/2020 12:20:51 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1541365

	registered interest
	date	09/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bereavement Counselling and Mental Health Services: Veterans
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will take steps to encourage local authorities to include clear signposting for local veteran-specific support services including (a) mental health services and (b) bereavement support.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83605
	answer	answer is ministerial correction date of answer 18/11/2022 answer text <p>Local authorities are encouraged to receive updates from the National Health Service which outline initiatives in support of the armed forces community, including information on Op COURAGE. Bereavement support is commissioned locally to meet the need of the local population. NHS England has developed guidance for integrated care boards which requires commissioners to ensure there is sufficient access to bereavement support services.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 18/11/2022 11:56:40 answering member 4492 label Biography information for Maria Caulfield
	tabling member	3960 label Biography information for Henry Smith

1541364

	registered interest
	date	09/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Suicide: Veterans
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will take steps to encourage local authorities to increase their engagement with veterans charities to help inform local authority suicide prevention action plans.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83604
	answer	answer is ministerial correction date of answer 15/11/2022 answer text <p>We continue to work with local authorities to ensure that suicide prevention action plans remain effective and include at-risk groups, such as veterans.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 15/11/2022 17:17:36 answering member 4492 label Biography information for Maria Caulfield
	tabling member	3960 label Biography information for Henry Smith

1382912

	registered interest
	date	29/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Ronapreve
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the B.1.1.529 covid-19 variant on the (a) efficacy of Ronapreve and (b) efficacy of Ronapreve in immunocompromised people.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83311
	answer	answer is ministerial correction date of answer 14/12/2021 answer text <p>The UK Health Security Agency have noted that B.1.1.529, or Omicron, could potentially have an impact on neutralising monoclonal antibody treatments. However, there is currently no confirmed evidence of reduced efficacy.</p><p>Regeneron is evaluating Ronapreve against the Omicron variant. Preliminary analyses from the company suggest that the antibodies in the cocktail may have the potential to retain activity against the Omicron variant, as well as the other existing variants of concern. Further in vitro data is expected over the next month.</p><p>On 17 September, Ronapreve was made available to treat the most vulnerable hospital patients in the United Kingdom through an interim clinical policy. This treatment will continue to be available this winter for hospitalised patients.</p><p>There will be ongoing monitoring (involving sample collection) of selected patients treated with nMABs (led by UK Health Security Agency). This will include monitoring the efficacy of the treatments against variants. The Therapeutics and Antivirals Taskforce will also keep the evidence under review, including how this could affect immunocompromised patients.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 14/12/2021 11:45:26 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1382911

	registered interest
	date	29/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when covid-19 vaccine records will be amended to show third doses that have been incorrectly recorded as boosters.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83310
	answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>For those who are severely immunosuppressed, the third primary COVID-19 vaccine dose is recorded as a booster vaccinations. A subsequent booster or fourth dose for eligible severely immunosuppressed patients after a further three months will be recorded as a second booster. Existing data systems support the recording of multiple boosters. All doses administered appear in an individual’s vaccination history and are recorded in the National Immunisation Management System and general practitioner record. An assessment determined that retrospectively updating or amending patient records in the immediate term could risk creating a data quality issue.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 83309 question first answered 02/02/2022 11:38:33 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1382910

	registered interest
	date	29/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Immunosuppression: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what measures are in place to ensure immunocompromised people’s covid-19 vaccine records are amended where third doses have been incorrectly recorded as boosters.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83309
	answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>For those who are severely immunosuppressed, the third primary COVID-19 vaccine dose is recorded as a booster vaccinations. A subsequent booster or fourth dose for eligible severely immunosuppressed patients after a further three months will be recorded as a second booster. Existing data systems support the recording of multiple boosters. All doses administered appear in an individual’s vaccination history and are recorded in the National Immunisation Management System and general practitioner record. An assessment determined that retrospectively updating or amending patient records in the immediate term could risk creating a data quality issue.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 83310 question first answered 02/02/2022 11:38:33 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1382909

	registered interest
	date	29/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of immunocompromised or immunosuppressed people have received (a) a Moderna third covid-19 vaccine dose and (b) the correct quantity of Moderna as a third dose.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83308
	answer	answer is ministerial correction date of answer 10/01/2022 answer text <p>The information is not held in the format requested. Whilst data for Moderna vaccine administrations is collected, information by clinical risk groups is not held centrally.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 10/01/2022 12:44:07 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1229593

	registered interest
	date	28/08/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will publish a national cancer recovery plan to tackle the backlog of cancer care resulting from the covid-19 outbreak.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	81799
	answer	answer is ministerial correction date of answer 21/09/2020 answer text <p>As set out in the Terms of Reference of a letter sent to NHS Providers on 31 July 2020, a National Cancer Taskforce will be established, and publish a national cancer recovery plan in the near future. The Terms of Reference are available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/cancer-forums-and-groups-terms-of-reference/" target="_blank">https://www.england.nhs.uk/publication/cancer-forums-and-groups-terms-of-reference/</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 21/09/2020 17:09:17 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1539224

	registered interest
	date	03/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Heart Diseases: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the answer of 18th July 2022 to Question 26734 on Heart Diseases: Screening, whether he is taking steps to reduce waiting times for echocardiography.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	78675
	answer	answer is ministerial correction date of answer 10/11/2022 answer text <p>The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ sets out how the National Health Service will recover and expand elective services over the next three years, including in echocardiography. To increase diagnostic activity and reduce patient waiting times, the Department has committed £2.3 billion for up to 160 community diagnostic centres (CDCs). As of 23 October 2022, CDCs have now completed 54,759 additional echocardiography checks since 13 July 2021.</p> answering member constituency Colchester answering member printed Will Quince question first answered 10/11/2022 12:42:45 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1378075

	registered interest
	date	12/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to empower clinicians to prescribe medicinal cannabis; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	73803
	answer	answer is ministerial correction date of answer 18/11/2021 answer text <p>Whether to prescribe any medicine is a clinical decision and the Government has enabled the prescription of cannabis-based products for medicinal use where it is clinically appropriate. The Chief Medical Officer and NHS England have written to doctors and pharmacists to highlight the available guidance on the prescribing and use of unlicensed medicines and to clarify the procedure for prescribing and supplying cannabis-based products for medicinal use. Health Education England has also published an e-learning module on medicinal cannabis.</p><p>The licensed cannabis-based medicine Epidyolex is prescribed and routinely funded by the National Health Service for Dravet syndrome and Lennox-Gastaut syndrome. The Medicines and Healthcare products Regulatory Agency has recently approved Epidyolex for a third form of epilepsy and it is now being assessed by the National Institute for Health and Care Excellence (NICE) for this indication. The licensed medicine Sativex is also routinely funded to treat moderate to severe spasticity in adults with multiple sclerosis. On 6 September, NHS England issued a reminder to clinical commissioning groups of NICE’s guidance relating to Sativex and will be monitoring its uptake.</p><p>The latest NICE guidelines demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based products on the NHS. The Government continues to support the establishment of clinical trials with NHS England and NHS Improvement and the National Institute for Health Research and from 1 April introduced a national patient registry to record patient outcomes. Since January 2020, the Refractory Epilepsy Specialist Clinical Advisory Service has been in place to provide advice and support for doctors to optimise the treatment of refractory epilepsy.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 73766 73767 73768 73769 question first answered 18/11/2021 10:20:44 answering member 4362 label Biography information for Edward Argar
	tabling member	3960 label Biography information for Henry Smith

1678334

	registered interest
	date	15/12/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	DNA: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure the security of DNA data held by (a) the NHS Genomic Medicine Service and (b) private providers of NHS healthcare; and whether she has had discussions with Cabinet colleagues on the potential for cyber attacks by foreign state-linked companies.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	7190
	answer	answer is ministerial correction date of answer 19/12/2023 answer text <p>Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation. In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas.</p><p>As part of the new UK Biological Security Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the United Kingdom and across the world. The Office for Life Sciences has begun this work, in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/12/2023 16:10:23 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3960 label Biography information for Henry Smith

720556

	registered interest
	date	13/04/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he expects the recently established cancer delivery plans to be published.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	70573
	answer	answer is ministerial correction date of answer 25/04/2017 answer text <p>Currently there is no co-ordinated date for publication of cancer delivery plans.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 25/04/2017 15:32:03 answering member 4080 label Biography information for David Mowat
	tabling member	3960 label Biography information for Henry Smith

1678211

	registered interest
	date	14/12/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Trade Competitiveness
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she is taking steps to protect (a) Bupa, (b) HCA Healthcare and (c) other major private healthcare providers from (i) BGI Group and (ii) MGI Tech.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	7019
	answer	answer is ministerial correction date of answer 19/12/2023 answer text <p>Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas.</p><p>As part of the new UK Biological Security Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the United Kingdom and across the world. The Office for Life Sciences has begun this work, in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 19/12/2023 16:02:28 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3960 label Biography information for Henry Smith

1462011

	registered interest
	date	11/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Immunosuppression: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the percentage of immunocompromised people receiving antiviral treatments for covid-19 within five days of first symptoms.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	695
	answer	answer is ministerial correction date of answer 24/05/2022 answer text <p>In England, 95% of eligible non-hospitalised patients who received an antiviral treatment were treated within five days from the start of COVID-19 symptoms. One such treatment, remdesivir, can be provided within seven days of symptom onset.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 24/05/2022 13:36:30 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1462009

	registered interest
	date	11/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Immunosuppression: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of immunocompromised patients who have received antiviral treatment in response to covid-19 and have subsequently (a) been hospitalised and (b) died with covid-19.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	693
	answer	answer is ministerial correction date of answer 20/05/2022 answer text <p>This information is not held centrally in the format requested.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 20/05/2022 10:05:04 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1462008

	registered interest
	date	11/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Immunosuppression: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many immunocompromised people have (a) been hospitalised with and (b) died from covid-19 since the MHRA authorised Evusheld for use in the UK.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	692
	answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The information requested is not held centrally.</p><p>On 17 March 2022, the Medicines and Healthcare products Regulatory Agency granted a conditional marketing authorisation for Evusheld. However, this authorisation outlined uncertainties for the treatment, including the length of protection and the dose required for efficacy against the Omicron variant.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 21/06/2022 09:58:07 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1462003

	registered interest
	date	11/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what timeframe UKHSA are working to in order to assess the effectiveness of Evusheld against the Omicron variant of covid-19.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	691
	answer	answer is ministerial correction date of answer 21/06/2022 answer text <p>The UK Health Security Agency continues to undertake further testing on Evusheld’s effectiveness against the Omicron variants. However, we are currently unable to confirm a timeframe for this process.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 21/06/2022 10:00:23 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1365995

	registered interest
	date	03/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people who are immunosuppressed have not been offered a second dose of the covid-19 vaccine; and how many of those people have blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	69065
	answer	answer is ministerial correction date of answer 02/03/2022 answer text <p>All those with immunosuppression aged 16 years old and over living in the United Kingdom have been offered a second primary dose of COVID-19 vaccine. Immunosuppressed children aged 12 to 15 years old have also now been offered a second primary dose. The offer of first primary doses to immunosuppressed children aged five to 11 years old commenced on 31 January 2022. Vaccination data for those with blood cancer is not held in the format requested.</p><p> </p><p>As of 20 February 2022, data for those formerly regarded as clinically extremely vulnerable, which includes the immunosuppressed and those with blood cancer, shows an uptake rate of over 93.9% for a second primary dose.</p><p><strong> </strong></p> answering member constituency Erewash answering member printed Maggie Throup question first answered 02/03/2022 10:47:06 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1365994

	registered interest
	date	03/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Immunosuppression: Coronavirus
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which (a) Minister in his Department and (b) senior official in NHS England have specific responsibility for policy relating to people who are immunosuppressed during the outbreak of covid-19; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	69064
	answer	answer is ministerial correction date of answer 22/11/2021 answer text <p>I have responsibility for policy relating to people who are immunosuppressed during the COVID-19 outbreak. For NHS England and NHS Improvement, the Chief Executive has this responsibility.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 22/11/2021 16:59:28 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1365993

	registered interest
	date	03/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people (a) in total and (b) with blood cancer have received a third dose of their primary course of the covid-19 vaccination; and if he will publish that data on a daily basis.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	69063
	answer	answer is ministerial correction date of answer 06/12/2021 answer text <p>The data requested is not available in the format requested. Daily data currently combines the total number of booster vaccinations and third primary doses, which is available at the following link:</p><p><a href="https://coronavirus.data.gov.uk/details/vaccinations" target="_blank">https://coronavirus.data.gov.uk/details/vaccinations</a></p><p>There are currently no plans to publish this data in a daily format. All individuals who have severe immunosuppression, including as a result of blood cancer, are eligible for their third primary dose of COVID-19 vaccine.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/12/2021 17:20:16 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1365992

	registered interest
	date	03/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Ronapreve
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people have been treated with Ronapreve for covid-19 (a) in each week and (b) in each clinical commissioning group area since that treatment became available; and how many of those recipients had blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	69062
	answer	answer is ministerial correction date of answer 06/12/2021 answer text <p>An interim clinical policy for Ronapreve (casirivimab and imdevimab) was published on 17 September 2021 and updated on 4 November. Since September 2021, over 1,200 patients in England have received this treatment.</p><p>NHS England and NHS Improvement collect information from trusts on usage based on the criteria set out in the policy for treatment of patients hospitalised due to COVID-19. The data collection is not designed to identify the number of such patients who have blood cancer. The information on the number of patients treated in each clinical commissioning group area and in each week is not currently available.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/12/2021 17:15:28 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1462001

	registered interest
	date	11/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 28 March 2022 to Question 141960, when he expects patients in the UK to have access to Evusheld as a preventative treatment for covid-19.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	690
	answer	answer is ministerial correction date of answer 17/05/2022 answer text <p>The UK Health Security Agency has yet to complete testing on Evusheld’s efficacy against the Omicron variant. The timing of these results is dependent on the testing assays being completed successfully, which will inform any decisions on potential deployment.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 689 question first answered 17/05/2022 13:12:03 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1462000

	registered interest
	date	11/05/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 28 April 2022 to Question 141960, what progress has been made on assessing Evusheld for treating immunocompromised patients.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	689
	answer	answer is ministerial correction date of answer 17/05/2022 answer text <p>The UK Health Security Agency has yet to complete testing on Evusheld’s efficacy against the Omicron variant. The timing of these results is dependent on the testing assays being completed successfully, which will inform any decisions on potential deployment.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 690 question first answered 17/05/2022 13:12:03 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1524205

	registered interest
	date	19/10/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the 10-Year Cancer Plan includes specific strategies to improve access to radiotherapy cancer treatments.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	66942
	answer	answer is ministerial correction date of answer 27/10/2022 answer text <p>Following a call for evidence for a new cancer plan held earlier this year, we received approximately 5,000 responses. Further information will be available in due course.</p> answering member constituency Colchester answering member printed Will Quince question first answered 27/10/2022 16:31:50 answering member 4423 label Biography information for Will Quince
	tabling member	3960 label Biography information for Henry Smith

1219228

	registered interest
	date	29/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Protective Clothing: Manufacturing Industries
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he is taking steps with UK manufacturers to ensure that the country is self-sufficient in PPE production and supporting British enterprises; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	66848
	answer	answer is ministerial correction date of answer 17/07/2020 answer text <p>Lord Deighton is leading the Government effort to unleash the potential of British industry to manufacture personal protective equipment (PPE) for the health and social care sectors to create self-sufficient production of PPE for the United Kingdom. We are building up UK manufacturing with signed contracts to manufacture over 2 billion items of PPE through UK-based manufacturers, including facemasks, visors, gowns and aprons.</p><p>This includes Survitec, a survival technology company, who began producing gowns at the beginning of June; Bolle, who manufacture protective eyewear, will make 6.5 million visors over the course of the pandemic; Jaguar Land Rover are now manufacturing 14,000 visors/week for healthcare staff; Don &amp; Low will be manufacturing 12 million metres squared of fabric for gowns over the next six months, with the first delivery expected later this month; Burberry is manufacturing non-surgical gowns at its factory in Castleford and sourcing masks through its supply chain. To date, the company has donated over 100,000 pieces of PPE to the National Health Service and healthcare charities.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/07/2020 11:25:01 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1172698

	registered interest
	date	22/01/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to reduce the number of people with blood cancer visiting their GP three or more times.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	6642
	answer	answer is ministerial correction date of answer 31/01/2020 answer text <p>In 2020, NHS England and NHS Improvement will continue to roll-out Rapid Diagnostic Centres across the country to upgrade and bring together the latest diagnostic equipment and expertise. They will initially focus on diagnosing cancers where patients often present with non-specific symptoms, such as blood cancer, and may go to their general practitioner many times before being sent for appropriate tests.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 31/01/2020 11:10:11 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

686153

	registered interest
	date	07/02/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Brentuximab Vedotin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure relapsed and refractory Hodgkin lymphoma patients continue to have access to brentuximab vedotin.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	63498
	answer	answer is ministerial correction date of answer 15/02/2017 answer text <p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) provides independent, evidence-based guidance for the National Health Service on whether drugs and treatments represent a clinically and cost effective use of NHS resources. NICE is appraising Brentuximab for this indication and recently consulted stakeholders on its draft recommendations. Brentuximab is currently available to NHS patients with relapsed and refractory Hodgkin lymphoma through the Cancer Drugs Fund.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 15/02/2017 13:39:18 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	3960 label Biography information for Henry Smith

1216122

	registered interest
	date	22/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pregnancy: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the financial effect of the covid-19 outbreak on parents of babies born needing neonatal care during the outbreak.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	62388
	answer	answer is ministerial correction date of answer 30/06/2020 answer text <p>The Government recognises that these are challenging times for everyone, but that it is an especially stressful time for parents with babies in neonatal intensive care units.</p><p>During the COVID-19 pandemic, services have been working hard to support parents to care for their babies as much as possible while still ensuring that services are safe.</p><p>The Department has no plans to introduce a bespoke fund to cover subsistence costs for parents with a baby receiving neonatal care during the COVID-19 outbreak.</p><p>The Government is providing funding for the charity Bliss to support families with babies that require neonatal care during the COVID-19 pandemic, as part of the Government’s United Kingdom-wide £750 million package of support for the voluntary sector announced by the Chancellor of the Exchequer in April 2020.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries grouped question UIN 62387 question first answered 30/06/2020 16:34:20 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	3960 label Biography information for Henry Smith

1216121

	registered interest
	date	22/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pregnancy: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to introduce financial support to cover subsistence costs for parents with a baby receiving neonatal care during the covid-19 outbreak.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	62387
	answer	answer is ministerial correction date of answer 30/06/2020 answer text <p>The Government recognises that these are challenging times for everyone, but that it is an especially stressful time for parents with babies in neonatal intensive care units.</p><p>During the COVID-19 pandemic, services have been working hard to support parents to care for their babies as much as possible while still ensuring that services are safe.</p><p>The Department has no plans to introduce a bespoke fund to cover subsistence costs for parents with a baby receiving neonatal care during the COVID-19 outbreak.</p><p>The Government is providing funding for the charity Bliss to support families with babies that require neonatal care during the COVID-19 pandemic, as part of the Government’s United Kingdom-wide £750 million package of support for the voluntary sector announced by the Chancellor of the Exchequer in April 2020.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries grouped question UIN 62388 question first answered 30/06/2020 16:34:20 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	3960 label Biography information for Henry Smith

678626

	registered interest
	date	25/01/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Foreign Nationals
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent progress his Department has made on recovering money from overseas visitors and other chargeable NHS patients.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	61532
	answer	answer is ministerial correction date of answer 02/02/2017 answer text <p>The National Health Service is a national, not an international, service. This Government was the first to introduce tough measures to clamp down on migrants accessing free NHS care, including introducing the immigration health surcharge.</p><p> </p><p>The initiatives we have implemented have meant the income identified from visitors and migrants has trebled from £89 million in 2012/13 to £289 million in 2015/16.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 02/02/2017 13:35:40 answering member 1542 label Biography information for Philip Dunne
	tabling member	3960 label Biography information for Henry Smith

671782

	registered interest
	date	11/01/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to NHS England's announcement on 6 December 2016 of an additional £200 million to improve local cancer services, what plans he has to ensure that that money will be used to roll out the Recovery Package and stratified pathways of follow-up care as costed in the Independent Cancer Taskforce report.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	59671
	answer	answer is ministerial correction date of answer 19/01/2017 answer text <p>The £200 million fund NHS England announced in December 2016 will be available to Cancer Alliances over the next two years to specifically support the areas the Cancer Taskforce strategy estimated would need additional investment including implementing the Recovery Package and rolling out stratified follow up pathways.</p><p> </p><p>Initial bids for funding are due on 18 January 2017. Clear guidance has been published and a regional and national panel will assess all bids received. The funding will be signed off by the NHS England Investment Committee.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 19/01/2017 11:56:42 answering member 4080 label Biography information for David Mowat
	tabling member	3960 label Biography information for Henry Smith

1361397

	registered interest
	date	19/10/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to ensure the experiences of, and quality of life for, people with a less survivable cancer are monitored by national mechanisms to allow issues in care and support to be identified and addressed.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	58815
	answer	answer is ministerial correction date of answer 05/11/2021 answer text <p>The Cancer Patient Experience Survey captures experiences from people treated for cancer, including those with less survivable cancers. Due to the need for statistical robustness, there is a time lag between the experience of treatment and the issue of the survey questionnaires. The Picker Institute reviewed the survey in 2018 and revised guidance to trusts to streamline preparations for the survey, ensured consistency in fieldwork across trusts to reduce delays in data collection and centralised checks on survey samples.</p><p>The national cancer quality of life survey in England was launched in September 2020 to introduce an innovative quality of life metric to track and respond to the long-term impact of cancer. The first report of the survey was published on 26 October 2021 and is available at the following link:</p><p><a href="https://www.england.nhs.uk/publication/cancer-quality-of-life-survey-summary-report-first-data-release-october-2021/" target="_blank">https://www.england.nhs.uk/publication/cancer-quality-of-life-survey-summary-report-first-data-release-october-2021/</a></p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 58814 question first answered 05/11/2021 13:55:32 answering member 4492 label Biography information for Maria Caulfield
	tabling member	3960 label Biography information for Henry Smith